Skip to content

Evaluation of a New Hysteroscopic Grasper for Endometrial Biopsy in Post-menopausal Patients

Evaluation of a New Hysteroscopic Grasper for Endometrial Biopsy in Post-menopausal Patients With Vaginal Bleeding and/or Endometrial Thickness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03427957
Enrollment
75
Registered
2018-02-09
Start date
2019-06-01
Completion date
2020-03-01
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Menopausal Bleeding, Post-Menopausal Endometrial Thickness

Keywords

Hysteroscopy, Endometrial biopsy, Menopause

Brief summary

Hysteroscopic endometrial biopsy is usually performed through the classic spoon grasper. Recently, a new hysteroscopic grasper with knurled terminal end and cutting jaws was designed, in order to improve feasibility of the procedure, reduce its duration and the discomfort for the patients. This study aims to compare the outcomes of the three hysteroscopic graspers for endometrial biopsy in post-menopausal patients.

Detailed description

Diagnostic hysteroscopy is currently the gold standard method to evaluate uterine cavity and tubal ostia, allowing also the visualization of vaginal walls and the cervical canal. Compared to the other available diagnostic techniques, hysteroscopy has the advantage of directly visualization the anatomical area to be investigated and allows to perform biopsy. The possibility of hysteroscopy-guided biopsy sampling is particularly important in order to get histological diagnosis. As recently suggested, the hysteroscopic biopsy of the endometrium has diagnostic accuracy of 90% for post-menopausal endometrial cancer. Currently, most diagnostic hysteroscopies are performed in outpatient setting, without anesthesia, using modern hysteroscopes with a 1.67 mm working channel. In particular, endometrial biopsy is usually performed through the classic spoon grasper or alligator grasper. Recently, a new hysteroscopic grasper with knurled terminal end and cutting jaws was designed, in order to improve feasibility of the procedure, reduce its duration and the discomfort for the patients. This study aims to compare the outcomes of the three hysteroscopic graspers for endometrial biopsy in post-menopausal patients.

Interventions

DIAGNOSTIC_TESTEndometrial biopsy with the new hysteroscopic grasper with knurled terminal end and cutting jaws

Hysteroscopic endometrial biopsy performed through the new grasper with knurled terminal end and cutting jaws.

DIAGNOSTIC_TESTEndometrial biopsy with the hysteroscopic spoon grasper

Hysteroscopic endometrial biopsy performed through the spoon grasper.

DIAGNOSTIC_TESTEndometrial biopsy with the hysteroscopic alligator grasper

Hysteroscopic endometrial biopsy performed through the alligator grasper.

Sponsors

Università degli Studi dell'Insubria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients will be blinded to the type of grasper used to perform hysteroscopic endometrial biopsy.

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Physiologic menopause * Vaginal bleeding or endometrial thickness (\>5 mm)

Exclusion criteria

* Hormonal replacement therapies * Other known causes of vaginal/cervical bleeding * Suspected or known cancer(s) * Premature or iatrogenic menopause * Uterine cervix stenosis

Design outcomes

Primary

MeasureTime frameDescription
Duration of the hysteroscopyDuring the hysteroscopyDuration of the hysteroscopic procedure, expressed in minutes and seconds.
Pain perceived by the patientDuring the hysteroscopySubjective evaluation of the pain perceived by the patient during the procedure, expressed through a 0-10 Visual Analogue Scale (VAS) score, where 0 means No pain and 10 The worst imaginable pain.

Secondary

MeasureTime frameDescription
Number of attemptsDuring the hysteroscopyNumber of attempts necessary to perform the biopsy
Size of the specimenDuring the hysteroscopySize of the specimen obtained through biopsy, expressed in mm2
Feasibility assessment by the operatorDuring the hysteroscopySubjective assessment by the operator of the feasibility of performing the biopsy, expressed through a 0-10 Visual Analogue Scale (VAS) score, where 0 means No feasible at all and 10 The most feasible event I could imagine.
PrecisionDuring the hysteroscopySubjective assessment by the operator of the precision of the biopsy, expressed through a 0-10 Visual Analogue Scale (VAS) score, where 0 means No precise at all and 10 The most precise event I could imagine.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026